ClariTestTM Non-Invasive Prenatal Screen
While most babies are born healthy, there is always a small risk for genetic conditions to occur, regardless of age or family history. ClariTest™, a non-invasive prenatal screen (NIPS), can be an important step in your prenatal care and can provide you with valuable information and peace of mind as you plan for your future.
ClariTest™ is a simple blood test performed during pregnancy that screens for the most common chromosome abnormalities. GenPath offers two different options:
- Basic ClariTest screens for Down syndrome, trisomy18, trisomy13, and sex chromosome abnormalities.
- ClariTest with microdeletions screens for the basic panel plus additional screening for certain microdeletions.
View Conditions Screened for with ClariTest Non-invasive Prenatal Screen with Microdeletions
What are Chromosomal Abnormalities?
Chromosomes are structures found in our cells that carry genetic information. Normally, we have 46 chromosomes, which come in pairs, in our cells. We inherit 23 chromosomes from each parent. The chromosome pairs are numbered from 1 to 22. The twenty-third pair is the sex chromosomes. Females generally have two X chromosomes and males generally have one X and one Y chromosome. Health and development problems can occur from chromosomal abnormalities, such as extra or missing chromosomes or pieces of chromosomes. The chance of having a baby with many chromosome abnormalities increases with the age of the mother.
What are Microdeletions?
The term “microdeletion” refers to a small, missing piece of a chromosome. Some microdeletions are known to cause specific genetic syndromes with major health impacts to the baby, including intellectual disabilities, heart and other birth defects, immune system problems, trouble feeding, and other complications that may need immediate care upon birth. The chance of having a baby with a microdeletion syndrome does not increase with the age of the mother.
Is ClariTest™ Right for Me?
This screening test is usually offered to pregnant women identified by their doctor to have an increased chance of a fetal chromosome abnormality. It may be an option for you to consider if you have a confirmed singleton or twin pregnancy of at least 10 weeks gestational age and meet any of the following criteria:
- You are considered to be of advanced maternal age at time of delivery (35 years or older for a singleton pregnancy or 32 years or older for a twin pregnancy)
- You have an abnormal or “positive” maternal serum screen
- Your ultrasound shows concerns or abnormalities with fetal growth and/or development
- You have a personal or family history suggestive of trisomies 21, 18, 13, or other sex-linked chromosome abnormalities
The Reliability You Seek
Today there are a number of genetic testing options available for expectant women and their healthcare providers. ClariTest™ may provide a clearer picture of chromosomal health—detecting even small abnormalities with a high degree of confidence. The false positive rate is low compared to Noninvasive prenatal screening (NIPS) offered at other laboratories and the test failure rate is the lowest in the industry. ClariTest™ can have “false negative” or “false positive” results. Diagnostic tests, such as CVS and amniocentesis, provide definitive diagnostic information and are recommended to confirm any abnormal NIPS result.